Why Is It So Hard to Sleep During Opioid Withdrawal?

Understanding withdrawal-related insomnia, what helps, and why sleep sometimes takes longer to recover.

People withdrawing from opioids often describe a rather frustrating combination. They're exhausted, but they can't sleep. Their muscles ache, their legs won't stay still, and just as they begin to drift off, another wave of sweating, chills, or anxiety wakes them up.

Some manage an hour or two. Others spend much of the night awake.

Is this insomnia? Certainly, in the ordinary sense. But opioid withdrawal creates some unusual problems for sleep, and the usual insomnia advice often isn't particularly helpful during the first few days.

Understanding why sleep becomes so difficult can help determine what to do about it.

Why opioid withdrawal interferes with sleep

Opioids affect much more than pain. They influence arousal, breathing, emotional regulation, and the neurological systems responsible for sleep.

With repeated opioid exposure, the nervous system adapts. Among other changes, the brain adjusts its activity in response to the ongoing effects of the drug.

When the opioid is reduced or removed, those adaptations don't immediately disappear.

One important consequence is increased activity in the brain's noradrenergic system, particularly pathways involved in alertness and the stress response. The locus coeruleus, a brainstem region responsible for much of the brain's norepinephrine signaling, becomes particularly important during withdrawal.

Heart rate increases. Sweating becomes more prominent. Temperature regulation becomes uncomfortable. Anxiety and physical restlessness may intensify.

The brain is effectively receiving signals to remain alert, even when the person is desperately tired.

Opioids can also alter normal sleep architecture, including the distribution of deep sleep and REM sleep. Withdrawal introduces another period of instability as these systems readjust.

Pain sensitivity may increase temporarily. Aches that were previously suppressed become more noticeable, and sleep deprivation itself can increase sensitivity to pain.

This creates an unpleasant cycle. Pain interferes with sleep. Poor sleep makes pain harder to tolerate. Both contribute to the physical discomfort of withdrawal.

And none of this is particularly responsive to buying a better pillow.

How long does withdrawal-related insomnia last?

That depends on the opioid involved, how long it was used, the degree of physical dependence, and whether withdrawal is medically managed.

For shorter-acting opioids, withdrawal symptoms often begin within hours of the last dose and become most intense over the next several days. Many physical symptoms improve substantially within a week.

Withdrawal from longer-acting medications, including methadone, may begin later and persist longer. Fentanyl exposure can also complicate the expected timeline.

Unfortunately, sleep doesn't always recover at the same rate as the other symptoms.

Some people begin sleeping better once the acute withdrawal symptoms settle. Others continue experiencing fragmented sleep, vivid dreams, frequent awakening, or difficulty falling asleep for weeks. In some cases, disturbances persist for months.

This doesn't necessarily mean something is permanently wrong with the sleep system.

The important question is whether the person is still experiencing active withdrawal, or whether insomnia has become a separate problem requiring treatment.

That distinction changes the approach.

Treating withdrawal is often the best way to improve sleep

During acute withdrawal, the most useful intervention may be better management of the withdrawal itself.

For someone gradually discontinuing prescription opioids used for chronic pain, severe insomnia can indicate that the taper is proceeding faster than the nervous system can comfortably accommodate.

The CDC's opioid prescribing guideline recommends considering a slower taper or temporarily pausing the reduction when significant withdrawal symptoms develop.

For people with opioid use disorder, medications such as buprenorphine and methadone can relieve withdrawal and reduce cravings. These are evidence-based treatments for opioid use disorder, not merely medications used to make detoxification more tolerable.

Remaining on maintenance treatment may be considerably safer than attempting to discontinue opioids altogether. Withdrawal management alone is not adequate treatment for opioid use disorder.

There are also non-opioid medications that can reduce specific withdrawal symptoms. One deserves particular attention.

Clonidine: calming the nervous system during withdrawal

Clonidine has been used for decades to manage opioid withdrawal. Although it was originally developed as a medication for high blood pressure, its effects on the central nervous system make it useful for a very different purpose.

Remember the increased noradrenergic activity that occurs during withdrawal?

Clonidine acts on alpha-2 adrenergic receptors, reducing sympathetic nervous system activity and decreasing norepinephrine release. In practical terms, it can help quiet some of the physiological overactivation associated with withdrawal.

Sweating, chills, elevated heart rate, and physical restlessness may improve. Some patients also experience less anxiety and agitation.

And when the body is less agitated, sleep may become easier.

There is reasonable evidence supporting its use for withdrawal. A Cochrane review of 26 randomized trials found that alpha-2 adrenergic agonists, including clonidine, were more effective than placebo for managing withdrawal symptoms.

Clonidine is not primarily a sleeping medication. Although it may cause sedation and reduce the physical symptoms that keep someone awake, it does not reliably eliminate withdrawal-related insomnia.

A person may feel less sweaty and restless but still struggle to sleep because of pain, restless legs, or disrupted sleep regulation.

That distinction matters when choosing treatment. Reducing withdrawal symptoms is useful, but sedation alone doesn't necessarily restore normal sleep.

Clonidine is commonly prescribed off-label for opioid withdrawal. Lofexidine is a related alpha-2 adrenergic agonist that is FDA-approved for opioid withdrawal symptoms in the United States. It tends to produce less hypotension than clonidine, although both medications have limitations.

Neither medication treats opioid cravings or the underlying opioid use disorder. When opioid use disorder is present, buprenorphine or methadone treatment is generally more effective at controlling withdrawal and supporting ongoing treatment.

Clonidine requires appropriate prescribing and monitoring because of blood-pressure and heart-rate effects, especially when someone is dehydrated from sweating, vomiting, or diarrhea. It should not be combined casually with other sedating medications or alcohol. After regular use, abrupt stopping can cause rebound hypertension, so discontinuation should follow the prescribing clinician's instructions.

For selected patients, clonidine can make withdrawal considerably more tolerable. Sometimes that improvement is enough to make sleep possible. It is better thought of as a treatment for the physiological symptoms of withdrawal, with potential secondary benefits for sleep, rather than a conventional hypnotic.

What can you do to improve sleep during withdrawal?

There are several practical measures that can help. None will completely override severe withdrawal, but they can reduce additional sources of sleep disruption.

Keep a reasonably consistent wake time. Your circadian system continues regulating sleep even during withdrawal. Getting out of bed at approximately the same time each morning, with some natural light exposure, helps preserve that rhythm.

Don't force yourself to sleep. Spending hours in bed worrying about how little sleep you're getting can increase arousal. If you're wide awake and becoming frustrated, get up briefly. Keep the lights dim, do something quiet, and return when sleepiness becomes more apparent.

Address physical discomfort. Hydration matters, particularly with sweating, diarrhea, or vomiting. A warm shower, comfortable bedding, a cool bedroom, and gentle stretching may help with muscle discomfort.

Be cautious with caffeine. If you have insomnia, stop caffeine. If any caffeine remains, finish it at least 12 hours before bed. A person who slept poorly may understandably reach for more coffee the next morning. Unfortunately, caffeine taken too late can contribute to another difficult night. See also Caffeine and Sleep.

Allow some flexibility. During significant acute withdrawal, this isn't the time to impose an aggressive sleep-restriction schedule. Rest is useful even when sleep is inconsistent. A short daytime nap may be reasonable if you're exhausted.

It may help to adjust expectations as well. Trying to achieve a perfect night during the worst of withdrawal can become another source of frustration. The immediate objective is to make sleep possible and reduce suffering while the underlying physiology settles.

What about sleeping pills?

When someone hasn't slept properly for several nights, the temptation to take something stronger is understandable.

But a medication that produces sedation doesn't necessarily restore normal sleep, and some combinations can be dangerous.

Benzodiazepines, alcohol, and other sedatives can suppress breathing, particularly if opioids remain in the body or the person is receiving opioid treatment. Combining these substances without appropriate medical supervision creates a serious overdose risk.

Over-the-counter antihistamines, including diphenhydramine and doxylamine, are not automatically better choices. They can produce substantial next-day drowsiness and may aggravate restless legs symptoms.

Gabapentin and pregabalin are sometimes considered for associated symptoms, but also require care. The FDA warns that these medications can increase the risk of respiratory depression when combined with opioids or other central nervous system depressants.

What about trazodone?

Trazodone is commonly prescribed off-label for sleep disturbances, including those occurring during opioid treatment. However, a randomized trial involving 137 patients receiving methadone maintenance treatment found no significant improvement in subjective or objectively measured sleep compared with placebo.

That study doesn't establish that trazodone is ineffective for every patient experiencing acute withdrawal. It does remind us that a commonly prescribed sleeping medication isn't necessarily an effective one.

Melatonin has a different role. It primarily acts as a circadian timing signal. It may be useful when sleep timing has become misaligned, but it doesn't directly address the heightened autonomic activity responsible for much of acute opioid withdrawal. For dose and indication context, see Melatonin: Endogenous Production, Dose, and What Evidence Actually Supports.

Medication decisions should account for the opioid involved, other prescriptions, breathing problems, blood pressure, and the specific symptoms preventing sleep.

When the legs won't stop moving

Restlessness is common during withdrawal. Sometimes, though, the symptoms resemble restless legs syndrome (RLS).

People with RLS experience an uncomfortable urge to move their legs, typically becoming worse during inactivity and in the evening. Walking or moving the legs provides temporary relief.

This can make falling asleep extraordinarily difficult.

Restless legs symptoms may appear during acute opioid withdrawal and sometimes persist beyond it. They should not automatically be dismissed as anxiety or ordinary withdrawal-related insomnia.

If the symptoms continue after withdrawal has stabilized, evaluation may include iron studies and assessment for other contributing factors.

The American Academy of Sleep Medicine's RLS guideline also recommends addressing medications that may worsen symptoms, including certain antihistamines.

A person taking an over-the-counter sleeping pill to treat insomnia may therefore be aggravating the very symptoms keeping them awake.

What if sleep doesn't improve after withdrawal?

Once the acute withdrawal period has passed, persistent insomnia deserves a more conventional sleep evaluation.

Chronic pain may remain poorly controlled. Anxiety or depression may become more apparent. Restless legs syndrome may persist. Circadian timing may become irregular after weeks of disrupted sleep.

Sleep-disordered breathing deserves consideration as well.

Chronic opioid exposure is associated with obstructive sleep apnea, central sleep apnea, and sleep-related hypoventilation. These conditions can cause persistent sleep fragmentation and daytime symptoms, even when the person doesn't recognize breathing difficulties during sleep.

For patients with persistent insomnia, cognitive behavioral therapy for insomnia (CBT-I) is the preferred long-term treatment. Major sleep medicine guidance, including from the American Academy of Sleep Medicine (AASM), treats CBT-I as first-line care for chronic insomnia. See CBT-I: The First-Line Treatment for Chronic Insomnia.

CBT-I addresses sleep-related arousal, inconsistent scheduling, excessive time spent awake in bed, and the learned behaviors that perpetuate insomnia. It isn't simply a collection of sleep hygiene tips.

Importantly, CBT-I should be adapted to the person's medical circumstances. Formal sleep restriction, for example, may be inappropriate during severe acute withdrawal or when substantial daytime impairment creates safety concerns.

Once withdrawal has stabilized, treating insomnia itself can be valuable. Observational research has linked greater insomnia severity with return to opioid use and nonfatal overdose after treatment; that association is not proof that insomnia caused either outcome, but it is another reason to take sleep complaints seriously during recovery. Related reading: Kratom, 7-OH, and Mitragynine Pseudoindoxyl.

When should you seek medical help?

Severe withdrawal symptoms deserve medical attention, particularly if you're unable to maintain hydration, experience fainting or confusion, or have significant cardiovascular symptoms.

Withdrawal involving alcohol or benzodiazepines at the same time can be considerably more dangerous and requires specific medical assessment. Opioid withdrawal during pregnancy also warrants medical supervision.

Persistent severe insomnia, worsening depression, or thoughts of self-harm should prompt additional evaluation. If you are in crisis, call or text 988.

One other risk is especially important. After reducing or discontinuing opioids, tolerance falls. Returning to a previously tolerated dose can cause a fatal overdose. People at risk should have access to naloxone and appropriate ongoing treatment.

Sleep usually improves, but it may need some help

There is no reliable shortcut that guarantees a good night's sleep during opioid withdrawal.

For the first several days, the priority is usually to manage withdrawal safely, reduce physical discomfort, and preserve a reasonable sleep schedule. Treatments such as clonidine can sometimes help by reducing the autonomic symptoms that keep the nervous system activated.

If insomnia continues after the acute symptoms have settled, the approach changes. At that point, it's worth looking for a persistent sleep disorder rather than simply waiting for the problem to disappear.

Sleep is an important part of recovery. It deserves treatment in its own right.

And fortunately, the first few miserable nights are not necessarily a prediction of what sleep will look like a month later.

This article is intended for education and does not replace individualized medical care. People discontinuing opioids should discuss withdrawal management with their prescribing or addiction-medicine clinician, particularly when other sedating medications, medical conditions, or opioid use disorder are involved.